Prot #D8241C00001: A Modular Phase I/II, Open-Label, Multi-Centre Study to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of AZD0466 Monotherapy or in Combination in Patients with Advanced Haematological Malignancies

Project: Research project

Project Details

StatusActive
Effective start/end date9/15/22 → 9/15/25

Funding

  • Parexel ((OE) Prot #D8241C00001 // (OE) Prot #D8241C00001)
  • AstraZeneca Pharmaceuticals LP ((OE) Prot #D8241C00001 // (OE) Prot #D8241C00001)